公开(公告)号：US20210053952A1

公开(公告)日：2021-02-25

申请号：US16959339

申请日：2019-01-10

Applicant: UCB Biopharma SRL

Inventor： Gareth Neil Brace ,  Rose Elizabeth Chappell ,  Gregory Foulkes ,  James Richard Frost ,  Helen Tracey Horsley ,  Elizabeth Pearl Jones ,  Fabien Claude Lecomte ,  James Thomas Reuberson ,  Monika-Sarah Elizabeth Dorothea Schulze ,  Richard David Taylor ,  Wei Tsung Yau ,  Zhaoning Zhu

IPC: C07D407/14 ,  C07D413/12 ,  C07D413/14 ,  C07D235/16 ,  C07D401/14

Abstract: A series of substituted fused bicyclic imidazole derivatives, including benzimidazole derivatives and analogues thereof, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including inflammatory and autoimmune disorders.

公开(公告)号：US11472794B2

公开(公告)日：2022-10-18

申请号：US16959339

申请日：2019-01-10

Applicant: UCB Biopharma SRL

Inventor： Gareth Neil Brace ,  Rose Elizabeth Bardell-Cox ,  Gregory Foulkes ,  James Richard Frost ,  Helen Tracey Horsley ,  Elizabeth Pearl Jones ,  Fabien Claude Lecomte ,  James Thomas Reuberson ,  Monika-Sarah Elizabeth Dorothea Schulze ,  Richard David Taylor ,  Wei Tsung Yau ,  Zhaoning Zhu

IPC: C07D403/12 ,  C07D413/12 ,  C07D407/14 ,  C07D235/16 ,  C07D401/14 ,  C07D413/14

Abstract: A series of substituted fused bicyclic imidazole derivatives, including benzimidazole derivatives and analogues thereof, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including inflammatory and autoimmune disorders.

公开(公告)号：US20240140951A1

公开(公告)日：2024-05-02

申请号：US18267235

申请日：2021-12-06

Applicant: UCB Biopharma SRL

Inventor： Gareth Neil Brace ,  Shuyu Chu ,  Anne Marie Foley ,  James Andrew Johnson ,  Timothy John Norman ,  Joanna Rachel Quincey ,  James Thomas Reuberson ,  Robert Straker ,  Robert James Townsend

IPC: C07D487/04 ,  A61P29/00 ,  C07D519/00

CPC classification number: C07D487/04 ,  A61P29/00 ,  C07D519/00

Abstract: A series of substituted imidazo[1,2-b]pyridazine derivatives as defined herein, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including inflammatory and autoimmune disorders.

公开(公告)号：US20230399328A1

公开(公告)日：2023-12-14

申请号：US18035332

申请日：2021-11-01

Applicant: UCB Biopharma SRL

Inventor： James Richard Frost ,  Gregory William Haslett ,  James Thomas Reuberson

IPC: C07D471/04

CPC classification number: C07D471/04

Abstract: A series of substituted dicyclopropyl methyl derivatives as defined herein, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including inflammatory and autoimmune disorders.

公开(公告)号：US20220242855A1

公开(公告)日：2022-08-04

申请号：US17621877

申请日：2020-06-24

Applicant: UCB Biopharma SRL

Inventor： Shuyu Chu ,  Helen Tracey Horsley ,  James Thomas Reuberson ,  Richard David Taylor ,  Zhaoning Zhu ,  Rose Elizabeth Chappell ,  Gregory William Haslett ,  Adam Peter Smalley ,  Nathaniel Julius Thomas Monck ,  Gareth Neil Brace ,  Prafulkumar Tulshibhai Chovatia

IPC: C07D405/14 ,  C07D487/04 ,  A61K45/06 ,  A61K31/501 ,  A61K31/519 ,  A61K31/4353 ,  C07D498/04 ,  A61K31/4245 ,  A61K31/4439 ,  A61K31/497 ,  C07D417/14

Abstract: A series of substituted fused bicyclic imidazole derivatives of formula (I), including benzimidazole derivatives and analogues thereof, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments including inflammatory and autoimmune disorders, wherein i. a. A represents C—R1 or N; B represents C—R2 or N; D represents C—R3 or N; E represents C—R4 or N; Z represents —CH(R5)N(H)CH2R6, —CH(R5)N(H)S(O)2R6, —C(═CR5aR5b)N(H)C(O)R6, —CH(R5)R7, —CH(R5)N(H)R7 or —CH(R5)C(O)N(H)R7; R0 represents hydrogen or C1-6 alkyl.

公开(公告)号：US20220227764A1

公开(公告)日：2022-07-21

申请号：US17614067

申请日：2020-06-24

Applicant: UCB Biopharma SRL

Inventor： Anne Marie Foley ,  Fabien Claude Lecomte ,  James Thomas Reuberson ,  Matthew Duncan Selby ,  Richard David Taylor ,  Paul Jonathan Hickford ,  Gareth Neil Brace

IPC: C07D471/04

Abstract: A series of substituted fused bicyclic imidazole derivatives, including imidazo[1,2-a]pyridine derivatives and analogues thereof, being potent modulators of human IL-17 activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including inflammatory and autoimmune disorders.